CD4+ lymphocytes and tuberculin skin test as survival predictors in pulmonary tuberculosis HIV-infected patients

International Journal of Epidemiology

Volumn 27, Issue 4, 1998, Pages 703-712

  Serrat, Carles ^a   Gómez, Guadalupe ^a   De Olalla, Patricia García ^b   Caylà, Joan A ^b  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Acquired immunodeficiency syndrome; CD4; Missing data; Survival analysis; Tuberculin skin test; Tuberculosis

Indexed keywords

CD4 ANTIGEN; TUBERCULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNE DEFICIENCY; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; REGRESSION ANALYSIS; SPAIN; SURVIVAL; T LYMPHOCYTE; TUBERCULIN TEST;

ADULT; AGED; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SPAIN; SURVIVAL ANALYSIS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 0031680677     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/27.4.703     Document Type: Article

References (40)

1. Raviglione M, Snider DE, Kochi A. Global epidemiology of tuberculosis. JAMA 1995;273:220-26.
2. Tuberculosis and AIDS. Statement on AIDS and tuberculosis. Geneve 1989. Global Programme on AIDS and Tuberculosis Programme, World Health Organization, in collaboration with the International Union Against Tuberculosis and Lung Disease. Bull Int Union Tuberc Lung Dis 1989;64:8-11.
3. World Health Organization. TB A Global Emergency. Geneve; WHO/TB/94. 177. 1994.
4. Richter C, Koelemay MJW, Swai ABM et al. Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis. Tuberc Lung Dis 1995;76:510-17.
5. World Health Organization. TB Groups at Risk. Geneve: WHO, 1996.
6. Jones B, Young S, Antoniskis D et al. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993;148:1292-97.
7. Bravo R, Soriano V, Martín R et al. Cuantificación de la viremia por el virus de la inmunodeficiencia humana en pacientes con progresión rápida y lenta de la enfermedad. Med Clin (Barc) 1995;104:530-34.
8. Cao Y, Qin L, Zhang L et al. Virologic and immunologic characteritzation of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-08.
9. De Cock KM. Interaction HIV/TB. Conference on Global Lung Health and the 1995 Annual Meeting on the IUATLD/UICTMR, Paris. Tuberc Lung Dis 1995;76(Suppl.2):5-6.
10. Caylà JA, Jansà JM, Artacoz L et al. Predictors of AIDS in a cohort of HIV-infected patients with pulmonary or pleural tuberculosis. Tuberc Lung Dis 1993;74:113-20.
11. Efron B. Missing data, imputation and the bootstrap (with discussion). JASA 1994;89:463-79.
12. Little RJA, Rubin DB. Statistical Analysis with Missing Data. New York: John Wiley, 1987.
13. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley, 1987.
14. Grupo de Trabajo sobre Tuberculosis (FIS-MSC). Consenso nacional para el control de la tuberculosis en España. Med Clin (Barc) 1992; 98:24-31.
15. Ocaña I, Ribera E, Martinez Vazquez JM. Diagnostic thoracocentesis and pleural biopsy. Ann Intern Med 1996;105:297-98.
16. Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993;41(No RR-17).
17. Phair J, Muñoz A, Detels R et al. The risk of Pneumocystis carinii pneumonia among men infected with Human Immunodeficiency Virus Type 1. N Engl J Med 1990;322:161-65.
18. Serrat C, Gómez G. Estimació de Paràmetres amb Dades Absents en un Estudi d'Anàlisi de Supervivència. Dept d'Estadística i Investigació Operativa. Universitat Politècnica de Catalunya 1995. DR 95/10.
19. Collett D. Modelling Survival Data in Medical Research. Texts in Statistical Science. London: Chapman & Hall, 1994.
20. Norussis MJ. SPSS/PV+ for the IBM PC/XT/AT. Chicago: SPSS Inc., 1986.
21. Epidemiological Graphics, Estimation and Testing Package (EGRET). Seattle, Washington: Statistics and Epidemiology Research Corporation, 1990.
22. Macroft A, Johnson M, Philips A. Factors affecting survival in patients with the acquired immunodeficiency syndrome. AIDS 1996;10: 1057-67.
23. Stoneburrer R, Laroche E, Prevots R et al. Survival in a cohort of human immunodeficiency virus infected tuberculosis patients in New York City. Implications for expansion or the AIDS case definition. Arch Intern Med 1992;152:2033-37.
24. Ellner J. Tuberculosis in the time of AIDS. Chest 1990;98:1051-52.
25. Poznasky MC, Coker R, Skinner C et al. HIV positive patients first presenting with an AIDS defining illness: characteristics and survival. Br Med J 1995;311:156-58.
26. Darby S, Ewart, Giangrande P et al. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet 1996;347:1573-79.
27. Vella S, Giuliano M, Florida M et al. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients. AIDS 1995;9:51-55.
28. Caylà JA, Jansà JM, Iglesias B et al. Epidemiología del síndrome de inmunodeficiencia adquirida en Barcelona (1981-1991)(I). Estudio descriptive y de tendencias temporales. Med Clin 1993;101:286-93.
29. Marco A, Guerrero RA, Rodríguez AM et al. Características de los casos de sida detectados en una prisión de Barcelona (1991-1993). Atención Primaria 1995;15:487-90.
30. Caylà JA, Marcos A, Bedoya A et al. Differential characteristics of AIDS patients with a history of imprisonment. Int J Epidemiol 1995;24: 1188-96.
31. Whalen C, Horsburch CR, Hom D et al. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-35.
32. Pape J, Jean J, Ho L et al. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342:268-72.
33. de Maron P, García A. La evolución de la infección VIH/SIDA en los países desarrollados. Impacto de la tuberculosis. Med Clin (Barc) 1993; 100:187-93.
34. Curtis R, Friedman S, Neaigus A et al. Implication of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rep 1994;109:321-27.
35. Gourevitch M, Wasserman W, Panero M et al. Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program. J Addictive Dis 1996;15:93-104.
36. Raistrick D, Hay A, Wolff K. Methadone maintenance and tuberculosis treatment. Br Med J 1996;313:925-26.
37. Milles G, Jones D. Relation between CD4 lymphocyte count and AIDS mortality, 1986-91. AIDS 1993;7:1383-86.
38. Levy JA. HIV pathogenesis and long-term survival. AIDS 1993;7: 1401-10.
39. Fernandez-Nogues F, Garau J, Gudiol F et al. Incidencia y diagnostico de la tuberculosis pulmonar en un servicio de medicina interna. Med Clin (Barc) 1983;81:651-54.
40. Whalen CC, Okwera A, Johnson J et al. Prognosis and survival in HIV-infected individuals tuberculosis patients: comparison of US and Uganda cohorts. Tuberc Lung Dis 1994;75(Suppl.I):66